Clinical trial

Role of Minocycline in First Episode Psychosis

NCT00916461

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Minocycline Normalized identity: minocyclineView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Role of Minocycline in First Episode Psychosis

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-05-01

PhasePHASE1 / PHASE2

Conditions

First Episode Psychosisunresolved

Interventions

MinocyclineDRUG · verified · RxNorm: minocycline

PlaceboDRUG

Sponsors & collaborators

Stanley Medical Research Institutelead sponsor

Institute of Psychiatry, Rawalpindi Medical College, Pakistancollaborator

Pakistan Institute of Living and Learningcollaborator

University of Sao Paulocollaborator

Mapped research locations

São PauloBrazil1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00916461 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.